Financial Ratios Hangzhou Huawang New Material Technology Co.,Ltd.
Equities
605377
CNE100005XR0
Paper Products
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.18 CNY | -1.74% |
|
+10.05% | +19.20% |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 6.75 | 8.39 | 6.35 | 5.95 | 4.45 | |||||
Return on Total Capital | 9.76 | 12.44 | 9.46 | 8.47 | 6.11 | |||||
Return On Equity % | 15.64 | 18.65 | 15.09 | 14.81 | 11.75 | |||||
Return on Common Equity | 15.78 | 18.82 | 15.18 | 14.86 | 11.76 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 24.38 | 21.74 | 18.02 | 18.4 | 15.39 | |||||
SG&A Margin | 3.91 | 2 | 1.98 | 1.92 | 2.21 | |||||
EBITDA Margin % | 21.39 | 19.34 | 16.68 | 16.64 | 14.71 | |||||
EBITA Margin % | 18.09 | 17.01 | 14.16 | 14.1 | 11.7 | |||||
EBIT Margin % | 18.02 | 16.95 | 14.11 | 14.05 | 11.63 | |||||
Income From Continuing Operations Margin % | 16.07 | 15.17 | 13.54 | 14.21 | 12.44 | |||||
Net Income Margin % | 16.13 | 15.26 | 13.6 | 14.24 | 12.44 | |||||
Net Avail. For Common Margin % | 16.13 | 15.26 | 13.6 | 14.24 | 12.44 | |||||
Normalized Net Income Margin | 11.29 | 11.03 | 9.7 | 9.6 | 7.63 | |||||
Levered Free Cash Flow Margin | 4.03 | 8.2 | 0.08 | -5.71 | 2.62 | |||||
Unlevered Free Cash Flow Margin | 4.46 | 8.26 | 0.17 | -5.6 | 2.7 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.6 | 0.79 | 0.72 | 0.68 | 0.61 | |||||
Fixed Assets Turnover | 2.66 | 3.3 | 3.21 | 3.25 | 2.81 | |||||
Receivables Turnover (Average Receivables) | 2.14 | 3.17 | 3.2 | 3.16 | 2.68 | |||||
Inventory Turnover (Average Inventory) | 2.89 | 4.2 | 3.69 | 3.43 | 3.5 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 2.25 | 2 | 2.29 | 2.24 | 2.25 | |||||
Quick Ratio | 1.77 | 1.55 | 1.78 | 1.76 | 1.82 | |||||
Operating Cash Flow to Current Liabilities | 0.19 | 0.36 | 0.29 | 0.21 | 0.25 | |||||
Days Sales Outstanding (Average Receivables) | 170.74 | 115.18 | 114.02 | 115.45 | 136.52 | |||||
Days Outstanding Inventory (Average Inventory) | 126.51 | 86.81 | 98.81 | 106.57 | 104.44 | |||||
Average Days Payable Outstanding | 201.11 | 162.63 | 161.99 | 171.74 | 177.8 | |||||
Cash Conversion Cycle (Average Days) | 96.15 | 39.36 | 50.84 | 50.28 | 63.16 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 10.03 | 0.05 | 6.65 | 9.32 | 15.6 | |||||
Total Debt / Total Capital | 9.11 | 0.05 | 6.23 | 8.53 | 13.5 | |||||
LT Debt/Equity | 2.25 | 0.02 | 0.1 | 0.05 | - | |||||
Long-Term Debt / Total Capital | 2.04 | 0.02 | 0.09 | 0.04 | - | |||||
Total Liabilities / Total Assets | 34.65 | 36.43 | 34.53 | 35.44 | 34.96 | |||||
EBIT / Interest Expense | 26.34 | 156.73 | 101.81 | 77.23 | 98.91 | |||||
EBITDA / Interest Expense | 31.27 | 179 | 120.72 | 91.73 | 125.62 | |||||
(EBITDA - Capex) / Interest Expense | 11.36 | 101.81 | 66.01 | 41.04 | 72.99 | |||||
Total Debt / EBITDA | 0.65 | 0 | 0.42 | 0.56 | 1.11 | |||||
Net Debt / EBITDA | -2.89 | -2.08 | -3.49 | -2.89 | -3.21 | |||||
Total Debt / (EBITDA - Capex) | 1.78 | 0 | 0.76 | 1.26 | 1.91 | |||||
Net Debt / (EBITDA - Capex) | -7.96 | -3.65 | -6.39 | -6.47 | -5.52 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -2.54 | 82.4 | 16.88 | 15.7 | -5.21 | |||||
Gross Profit, 1 Yr. Growth % | 32.35 | 75.28 | -3.11 | 18.14 | -20.75 | |||||
EBITDA, 1 Yr. Growth % | 35.31 | 64.9 | 0.82 | 15.38 | -16.18 | |||||
EBITA, 1 Yr. Growth % | 40.19 | 71.51 | -2.66 | 15.2 | -21.39 | |||||
EBIT, 1 Yr. Growth % | 40.33 | 71.6 | -2.7 | 15.19 | -21.54 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 51.66 | 72.14 | 4.36 | 21.4 | -17.06 | |||||
Net Income, 1 Yr. Growth % | 52.23 | 72.53 | 4.18 | 21.13 | -17.18 | |||||
Normalized Net Income, 1 Yr. Growth % | 51.18 | 78.24 | 2.75 | 14.54 | -24.62 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 51.78 | 29.76 | -7.01 | 17.81 | -17.88 | |||||
Accounts Receivable, 1 Yr. Growth % | 7.36 | 37.17 | -0.63 | 36.42 | -6.74 | |||||
Inventory, 1 Yr. Growth % | 35.39 | 25.79 | 50.15 | 6.91 | -14.07 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 73.68 | 32.02 | 11.29 | 16.99 | 3.18 | |||||
Total Assets, 1 Yr. Growth % | 73.22 | 17.96 | 37.28 | 12.67 | -1.98 | |||||
Tangible Book Value, 1 Yr. Growth % | 113.73 | 15.36 | 42.46 | 10.37 | -1.1 | |||||
Common Equity, 1 Yr. Growth % | 106.17 | 14.81 | 41.6 | 11.14 | -1.14 | |||||
Cash From Operations, 1 Yr. Growth % | -33.31 | 145.25 | 2.28 | -18.62 | 17.66 | |||||
Capital Expenditures, 1 Yr. Growth % | 101.39 | 11.79 | 6.15 | 40.68 | -36.39 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -67.03 | 270.6 | -98.82 | -10.31K | -143.44 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -65.21 | 237.85 | -97.6 | -4.38K | -145.56 | |||||
Dividend Per Share, 1 Yr. Growth % | - | 21.32 | 0 | 111.57 | 10.72 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -8.48 | 33.33 | 46.01 | 16.28 | 4.72 | |||||
Gross Profit, 2 Yr. CAGR % | 19.94 | 46.73 | 30.32 | 6.99 | -3.24 | |||||
EBITDA, 2 Yr. CAGR % | 25.66 | 49.37 | 28.94 | 7.85 | -1.65 | |||||
EBITA, 2 Yr. CAGR % | 30.07 | 55.06 | 29.21 | 5.9 | -4.84 | |||||
EBIT, 2 Yr. CAGR % | 30.32 | 55.18 | 29.21 | 5.87 | -4.93 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 43.77 | 61.58 | 34.03 | 12.56 | 0.35 | |||||
Net Income, 2 Yr. CAGR % | 44.02 | 62.07 | 34.07 | 12.34 | 0.16 | |||||
Normalized Net Income, 2 Yr. CAGR % | 46.91 | 64.15 | 35.33 | 8.48 | -7.08 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 43.99 | 40.09 | 9.85 | 4.67 | -1.58 | |||||
Accounts Receivable, 2 Yr. CAGR % | 9.19 | 21.36 | 16.75 | 16.43 | 12.79 | |||||
Inventory, 2 Yr. CAGR % | 13.61 | 30.5 | 37.43 | 26.7 | -4.15 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 48.5 | 51.43 | 21.21 | 14.1 | 9.87 | |||||
Total Assets, 2 Yr. CAGR % | 41.4 | 42.95 | 27.26 | 24.37 | 5.09 | |||||
Tangible Book Value, 2 Yr. CAGR % | 60.65 | 57.02 | 28.19 | 25.39 | 4.48 | |||||
Common Equity, 2 Yr. CAGR % | 56.55 | 53.85 | 27.51 | 25.45 | 4.82 | |||||
Cash From Operations, 2 Yr. CAGR % | -3.69 | 27.89 | 58.38 | -8.77 | -2.15 | |||||
Capital Expenditures, 2 Yr. CAGR % | 122.56 | 50.05 | 8.93 | 22.2 | -5.4 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -37.77 | 10.53 | -79.11 | -2.85 | 566.45 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -37.42 | 8.42 | -71.57 | -4.21 | 341.92 | |||||
Dividend Per Share, 2 Yr. CAGR % | - | - | 10.15 | 45.45 | 53.05 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | -4.14 | 15.17 | 27.6 | 35.11 | 8.63 | |||||
Gross Profit, 3 Yr. CAGR % | 4.41 | 32.76 | 27.77 | 26.13 | -3.2 | |||||
EBITDA, 3 Yr. CAGR % | 7.66 | 37.58 | 31.03 | 24.25 | -0.84 | |||||
EBITA, 3 Yr. CAGR % | 8.83 | 42.63 | 32.77 | 24.36 | -4.12 | |||||
EBIT, 3 Yr. CAGR % | 8.77 | 42.84 | 32.82 | 24.36 | -4.2 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 13.45 | 52.66 | 39.67 | 29.68 | 1.67 | |||||
Net Income, 3 Yr. CAGR % | 13.58 | 52.96 | 39.87 | 29.61 | 1.49 | |||||
Normalized Net Income, 3 Yr. CAGR % | 12.33 | 56.69 | 40.42 | 28.01 | -3.91 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 10.8 | 38.92 | 22.2 | 12.44 | -3.43 | |||||
Accounts Receivable, 3 Yr. CAGR % | 9.89 | 17.82 | 13.53 | 22.97 | 8.13 | |||||
Inventory, 3 Yr. CAGR % | 10.14 | 17.54 | 36.75 | 26.39 | 11.32 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 26.6 | 42.79 | 36.65 | 19.79 | 10.34 | |||||
Total Assets, 3 Yr. CAGR % | 31.4 | 33.11 | 41.03 | 22.19 | 14.88 | |||||
Tangible Book Value, 3 Yr. CAGR % | 40.72 | 43.86 | 52.01 | 21.96 | 15.85 | |||||
Common Equity, 3 Yr. CAGR % | 41.28 | 41.18 | 49.66 | 21.8 | 15.88 | |||||
Cash From Operations, 3 Yr. CAGR % | 2.98 | 31.52 | 18.71 | 26.85 | -0.69 | |||||
Capital Expenditures, 3 Yr. CAGR % | 90.71 | 76.92 | 33.7 | 18.63 | -1.7 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -40.92 | 12.8 | -75.68 | 51.73 | -25.67 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -37.99 | 9.79 | -69.59 | 45.74 | -25.19 | |||||
Dividend Per Share, 3 Yr. CAGR % | - | - | - | 36.92 | 32.81 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 22.19 | 16.89 | 13.43 | 15.62 | 17.9 | |||||
Gross Profit, 5 Yr. CAGR % | 25.2 | 24.38 | 12.4 | 21.78 | 14.32 | |||||
EBITDA, 5 Yr. CAGR % | 27.7 | 26.87 | 15.71 | 24.81 | 16.82 | |||||
EBITA, 5 Yr. CAGR % | 29.63 | 32.66 | 16.57 | 26.61 | 16.21 | |||||
EBIT, 5 Yr. CAGR % | 29.61 | 32.67 | 16.53 | 26.71 | 16.19 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 33.67 | 34.56 | 21.27 | 35.14 | 22.36 | |||||
Net Income, 5 Yr. CAGR % | 33.76 | 34.71 | 21.37 | 35.19 | 22.38 | |||||
Normalized Net Income, 5 Yr. CAGR % | 36.52 | 37.98 | 21.02 | 35.26 | 19.04 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 22.36 | 22.46 | 10.34 | 24.04 | 12.07 | |||||
Accounts Receivable, 5 Yr. CAGR % | 26.68 | 25.95 | 12.59 | 17.26 | 13.24 | |||||
Inventory, 5 Yr. CAGR % | 24.58 | 19.34 | 20.34 | 21.12 | 18.63 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 35.26 | 19.47 | 24.42 | 30.54 | 25.23 | |||||
Total Assets, 5 Yr. CAGR % | 39 | 27.89 | 29.73 | 29.54 | 25.37 | |||||
Tangible Book Value, 5 Yr. CAGR % | 51.05 | 38.95 | 35.57 | 36.17 | 30.84 | |||||
Common Equity, 5 Yr. CAGR % | 50.95 | 38.74 | 35.6 | 34.66 | 29.79 | |||||
Cash From Operations, 5 Yr. CAGR % | 6.07 | 57.3 | 22.33 | 13.62 | 9.88 | |||||
Capital Expenditures, 5 Yr. CAGR % | 91.63 | 78.87 | 52.44 | 52.58 | 16.42 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -20.23 | -1.74 | -61.02 | 6.23 | -12.91 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -17.8 | -2.76 | -54.6 | 3.93 | -13.24 | |||||
Dividend Per Share, 5 Yr. CAGR % | 33.26 | - | - | - | - |
Select your edition
All financial news and data tailored to specific country editions
















